End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
60.6 TWD | -1.78% |
|
-0.82% | -12.68% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
CDMO
95.1
%
| 3 | 57.5 % | 40 | 95.1 % | +1,358.80% |
New Anticancer Drug
4.9
%
| 2 | 42.5 % | 2 | 4.9 % | +1.40% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
96.2
%
| 3 | 72.9 % | 40 | 96.2 % | +1,065.18% |
Others
3.8
%
| 1 | 27.1 % | 2 | 3.8 % | +21.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Heidi Wang
CEO | Chief Executive Officer | - | 23-06-01 |
Chih Chuan Chen
DFI | Director of Finance/CFO | - | - |
Kuo Lin Kao
AUD | Comptroller/Controller/Auditor | - | 17-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ta Meng Tseng
BRD | Director/Board Member | 66 | 13-02-06 |
Chih Chuan Chen
DFI | Director of Finance/CFO | - | - |
Tai Chang Wang
BRD | Director/Board Member | 65 | - |
Lung Yeh Cho
BRD | Director/Board Member | - | 13-02-06 |
Chen Yue Feng
BRD | Director/Board Member | - | - |
Chung Ming Chang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 229,439,000 | 151,802,374 ( 66.16 %) | 191,000 ( 0.0832 %) | 66.16 % |
Company contact information
![address OBI Pharma, Inc.(4174)](https://cdn.zonebourse.com/static/address/20707242.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-12.68% | 434M | |
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |
- Stock Market
- Equities
- 4174 Stock
- Company OBI Pharma, Inc.